The U.S. inked a deal to provide 380 million Covid-19 tests manufactured by
The announcement Thursday marks the next step in Biden’s plan to counter surging cases of the omicron variant of the coronavirus. At the same time, the U.S. is facing a shortage of tests and long lines persist at testing centers across the country. Retailers are having trouble keeping at-home kits in stock and are raising prices.
It’s not clear how many of the tests will be available in the coming weeks, though Biden has promised to make a portion of them available by the end of January. The White House plans to launch a website for people to request them.
The Biden administration signed a few agreements in recent weeks to boost the supply of rapid Covid-19 tests. It finalized a $51.6 million deal last week with logistics company Goldbelt Security LLC to provide Covid-19 tests. It signed a separate contract with Revival Health Inc. to buy 13.3 million over-the-counter test kits. In late December, it signed a $136.7 million deal with Millipore Sigma, the life science division of
Separately, private insurers will reimburse Americans for at-home tests beginning January 15.
To contact the reporter on this story:
To contact the editors responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.